drug

(doxylamine + pyridoxine hydrochloride) DR

Marketedupdated 2mo ago

by Duchesnay USA Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Feb 18, 2033

~6.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Feb 18, 2033formulationUS 9089489
Feb 18, 2033formulationUS 9375404
Feb 18, 2033formulationUS 9526703
Feb 18, 2033formulationUS 9937132

Trials studying (doxylamine + pyridoxine hydrochloride) DR

phase3The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescentssuspendedn=274